• Vt. to get $1.1 million drug settlement
    November 17,2012
    • Email Article
    •  
    •  Print Article
     
    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.
    • Email Article
    •  
    •  Print Article
    2 Comments
    MORE IN Vermont News
    BARRE — A Barre woman pleaded not guilty Friday to threatening Department for Children and... Full Story
    MONTPELIER — The state has issued a request for proposals to study the beleaguered Vermont Health... Full Story
    MONTPELIER — A bipartisan deal has been reached by two key members of the U.S. Full Story
    More Articles